Bliss GVS Pharma Limited — Board Meeting, 12-05-2026: Outcome of Board Meeting

Bliss GVS Pharma's board approved audited consolidated financial results for the quarter and year ended March 31, 2026: Revenue Rs. 809.73 Cr, Net Profit Rs. 96.87 Cr. A final dividend of Re 1 per share was proposed. The company also expanded by incorporating two new subsidiaries.